Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 4, 2025
Decision-making in valve reintervention: Redo-Transcatheter aortic valve replacement vs. explant surgeryLior Lupu, Pavan Reddy, Dan Haberman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2014
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantationErin Gatza, Thomas Braun, John E Levine, et al.
Cell Stem Cell|September 4, 2024
Inflammation-induced epigenetic imprinting regulates intestinal stem cellsDongchang Zhao, Visweswaran Ravikumar, Tyler J Leach, et al.
Blood|December 18, 2024
Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host diseaseYui Kambara, Hideaki Fujiwara, Akira Yamamoto, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 16, 2024
High-risk percutaneous coronary intervention with or without mechanical circulatory support: Will Impella show superiority in the PROTECT IV randomized trial?Kalyan R Chitturi, Cheng Zhang, Waiel Abusnina, et al.
Nature Medicine|October 19, 2023
Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantationMary M Riwes, Jonathan L Golob, John Magenau, et al.
Blood|October 8, 2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host diseaseJames L M Ferrara, Andrew C Harris, Joel K Greenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective SeriesAttaphol Pawarode, Shin Mineishi, Pavan Reddy, et al.
Bone Marrow Transplantation|July 21, 2015
FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AMLYeohan Song, John Magenau, Yumeng Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-diseaseJohn M Magenau, Xuemei Qin, Isao Tawara, et al.
Pageof 20